Evidence map›Paper›PMID 27777419›Full record

ArticleMolecular psychiatry2017

Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein.

G Kaur, M Pawlik, S E Gandy, M E Ehrlich, J F Smiley, E Levy

Abstract read
In one paragraph

Article in Molecular psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Towards a Unitary Hypothesis of Alzheimer's Disease Pathogenesis.Journal of Alzheimer's disease : JAD · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

G KaurCenter of Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA.
M PawlikCenter of Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA.
S E GandyDepartments of Neurology and Psychiatry, and Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
M E EhrlichDepartments of Neurology and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J F SmileyCenter of Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA.
E LevyCenter of Dementia Research, Nathan S. Kline Institute, Orangeburg, NY, USA.
Nathan Kline Institute for Psychiatric Research · USIcahn School of Medicine at Mount Sinai · US

Funding

Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal functionP01AG017617 · NIA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI NIXON, RALPH A. · 2000 to 2021
$40.0M
VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHIMMING, CORBETT · 1985 to 2019
$37.9M
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's DiseaseU01AG046170 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WANG, MINGHUI, ZHANG, BIN · 2013 to 2022
$26.0M
Modulation of Olfactory Sensory Function by Amyloid-betaR01AG037693 · NIA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI LEVY, EFRAT, NIXON, RALPH A. · 2011 to 2015
$1.6M
Animal models for cerebral amyloid angiopathyR01NS042029 · NINDS · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI LEVY, EFRAT · 2002 to 2006
$1.5M
NIA NIH HHS P01 AG017617NIA NIH HHS P50 AG005138NIA NIH HHS R01 AG037693NIA NIH HHS U01 AG046170NINDS NIH HHS R01 NS042029
6 · The paper itself

Abstract

Recent data suggest that intraneuronal accumulation of metabolites of the amyloid-β-precursor protein (APP) is neurotoxic. We observed that transgenic mice overexpressing in neurons a human APP gene harboring the APP

Indexed as

alpha-SynucleinAlzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsBrainCerebral CortexDisease Models, AnimalHippocampusHumansLysosomal-Associated Membrane Protein 2MiceMice, TransgenicNeuronsPeptide FragmentsProteinsalpha-SynucleinAmyloid beta-PeptidesAmyloid beta-Protein PrecursorLysosomal-Associated Membrane Protein 2lysosomal proteinsPeptide FragmentsProteins

Identifiers

PMID27777419
PMCPMC5405008
OpenAlexW2536500518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.